BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18307140)

  • 1. Angiosarcoma of the eyelid and periorbital region. Experience in Leiden with iridium192 brachytherapy and low-dose doxorubicin chemotherapy.
    de Keizer RJ; de Wolff-Rouendaal D; Nooy MA
    Orbit; 2008; 27(1):5-12. PubMed ID: 18307140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement.
    DeMartelaere SL; Roberts D; Burgess MA; Morrison WH; Pisters PW; Sturgis EM; Ho V; Esmaeli B
    Head Neck; 2008 May; 30(5):639-46. PubMed ID: 18213722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiosarcoma of the eyelid: a clinicopathologic comparison between isolated unilateral tumors and tumors demonstrating extrapalpebral involvement.
    Papalas JA; Manavi CK; Woodward JA; Sangueza OP; Cummings TJ
    Am J Dermatopathol; 2010 Oct; 32(7):694-9. PubMed ID: 20559124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006).
    Bulakowski EJ; Philibert JC; Siegel S; Clifford CA; Risbon R; Zivin K; Cronin KL
    J Am Vet Med Assoc; 2008 Jul; 233(1):122-8. PubMed ID: 18593321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brachytherapy with 192Ir as treatment of carcinoma of the tarsal structure of the eyelid.
    Conill C; Sánchez-Reyes A; Molla M; Vilalta A
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1326-9. PubMed ID: 15275716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late chest wall toxicity after MammoSite breast brachytherapy.
    Brashears JH; Dragun AE; Jenrette JM
    Brachytherapy; 2009; 8(1):19-25. PubMed ID: 18955019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interstitial brachytherapy of peri-orificial skin carcinomas on the face].
    Rio E; Bardet E; Ferron C; Peuvrel P; Supiot S; Campion L; Beauvillain De Montreuil C; Mahe MA; Dreno B
    Cancer Radiother; 2006 May; 10(3):101-6. PubMed ID: 16529964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early breast cancer treated with conservative surgery, adjuvant chemotherapy, and delayed accelerated partial breast irradiation with high-dose-rate brachytherapy.
    Gómez-Iturriaga A; Pina L; Cambeiro M; Martínez-Regueira F; Aramendía JM; Fernández-Hidalgo O; Martínez-Monge R
    Brachytherapy; 2008; 7(4):310-5. PubMed ID: 18778971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy following recurrent angiosarcoma of the ovary--a case report and review of literature.
    Jha S; Chan KK; Poole CJ; Rollason TP
    Gynecol Oncol; 2005 Jun; 97(3):935-7. PubMed ID: 15943995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment of angiosarcoma with liposomal-encapsulated doxorubicin].
    Voss A; Seitz CS; Rose C; Bröcker EB; Goebeler M
    Hautarzt; 2001 Oct; 52(10):895-8. PubMed ID: 17690822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous angiosarcoma is a rare aggressive malignant vascular tumour of the skin.
    Wollina U; Hansel G; Schönlebe J; Averbeck M; Paasch U; Uhl J; Hindemann W; Simon JC
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):964-8. PubMed ID: 21108661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the treatment of keloid scars still a challenge in 2006?
    De Lorenzi F; Tielemans HJ; van der Hulst RR; Rhemrev R; Nieman FH; Lutgens LC; Boeckx WD
    Ann Plast Surg; 2007 Feb; 58(2):186-92. PubMed ID: 17245147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
    Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience.
    Martelli H; Haie-Meder C; Branchereau S; Franchi-Abella S; Ghigna MR; Dumas I; Bouvet N; Oberlin O
    J Pediatr Surg; 2009 Jan; 44(1):190-6. PubMed ID: 19159742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary localized stages I and II non-Hodgkin's lymphoma of the nasopharynx: a retrospective 17-year single institutional experience.
    Mohammadianpanah M; Ahmadloo N; Mozaffari MA; Mosleh-Shirazi MA; Omidvari S; Mosalaei A
    Ann Hematol; 2009 May; 88(5):441-7. PubMed ID: 18931844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX).
    de Crevoisier R; Slimane K; Sanfilippo N; Bossi A; Albano M; Dumas I; Wibault P; Fizazi K; Gerbaulet A; Haie-Meder C
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1150-6. PubMed ID: 19395183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary angiosarcoma of the breast: clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic.
    Nascimento AF; Raut CP; Fletcher CD
    Am J Surg Pathol; 2008 Dec; 32(12):1896-904. PubMed ID: 18813119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of radiation therapy after incomplete resection of penile cancer.
    Langsenlehner T; Mayer R; Quehenberger F; Prettenhofer U; Langsenlehner U; Pummer K; Kapp KS
    Strahlenther Onkol; 2008 Jul; 184(7):359-63. PubMed ID: 19016034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy.
    Ghadjar P; Keller T; Rentsch CA; Isaak B; Behrensmeier F; Stroux A; Thalmann GN; Aebersold DM
    Brachytherapy; 2009; 8(1):45-51. PubMed ID: 19038584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome analysis in "high-risk" versus "low-risk" patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413 trial: five-year results.
    Patel RR; Christensen ME; Hodge CW; Adkison JB; Das RK
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):970-3. PubMed ID: 18313521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.